Scandinavian ChemoTech AB (publ) reported earnings results for the fourth quarter ended December 31, 2023. For the fourth quarter, the company reported sales was SEK 0.507 million compared to SEK 0.227 million a year ago. Revenue was SEK 0.651 million compared to SEK 0.233 million a year ago.

Net loss was SEK 5.15 million compared to SEK 6.5 million a year ago. Basic loss per share from continuing operations was SEK 0.35 compared to SEK 0.59 a year ago.